Navigation Links
PuraMed BioScience, Inc. Announces LipiGesic®M, Their Unique Migraine Treatment, is Now Available for Purchase at CVS, the 2nd Largest Drug Chain in the United States
Date:1/25/2012

SCHOFIELD, Wis., Jan. 25, 2012 /PRNewswire/ -- PuraMed BioScience, Inc. (OTCBB: PMBS) announced today that LipiGesic M, their clinically proven effective and safe, all natural product for the treatment of migraine headaches, is now available for purchase at CVS, the 2nd Largest Drug Chain in the United States. With the addition of over 7,000 CVS locations, LipiGesic®M is now available in approximately 15,000 stores nationwide.

"We are pleased to now have our LipiGesic®M product available in both the #1 and #2 Drug Chain stores in the United States.  Between the nearly 8,000 Walgreens and 7,000 CVS locations nationwide, we believe our product is gaining the exposure needed to generate significant revenue," stated Russ Mitchell, CEO of PuraMed BioScience.

PuraMed BioScience, Inc. anticipates announcing additional distribution in chain drug stores in the near future.

About PuraMed BioScience, Inc.:
PuraMed BioScience, Inc. engages in the research, development and marketing of non-prescription medicinal and healthcare products.  PuraMed has completed a double blind placebo clinical trial for its leading product, LipiGesic®M, a sublingual acute treatment for the relief from migraine headaches, which was published in the top-tier medical journal, Headache. Please see the following link to view the abstract of that study.  http://onlinelibrary.wiley.com/doi/10.1111/j.1526-4610.2011.01910.x/abstract.  LipiGesic®M has national distribution and is available nationwide in some of the largest chain drug stores in the United States.  In addition to LipiGesic®M, the Company also has plans to launch LipiGesic®H for tension-type headaches as well as LipiGesic®PM which provides a remedy for insomnia and other sleep disorders.

For more information on PuraMed, visit the Company website at www.PuraMedBioScience.com, and join the Company's group page on Facebook by searching "PuraMed BioScience."

Forward-Looking Statements:  
This news release contains forward-looking statements regarding PuraMed BioScience and its future business plans, which statements involve known and unknown risks and uncertainties. Such risks and uncertainties may cause actual results and future achievements of PuraMed BioScience to be materially different than those implied by these forward-looking statements. PuraMed BioScience has and undertakes no obligation to provide public updates and revisions to these forward-looking statements to reflect any changes in its expectations of future events.

Contact:
PuraMed BioScience, Inc.
Russell Mitchell, Chairman and CEO
715-359-6373
rmitchell@PuramedBioScience.com
www.PuramedBioScience.com

Investor Relations:
Investor Awareness, Inc.
Tony Schor or James Foy
847-945-2222
www.investorawareness.com


'/>"/>
SOURCE PuraMed BioScience, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. PuraMed BioScience, Inc. Has Its Lead Product, LipiGesic®M Featured in Flaherty Financial News
2. Crown Bioscience, Inc. Announces Closing of Series C Financing
3. Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce Positive Results of Phase III Study of Milnacipran for the Management of Fibromyalgia
4. Integware Announces Systems Integrator Agreement With Siemens PLM Software
5. Millennium Research Institute Announces 2012 Educational Initiatives
6. Tris Pharma Announces Appointment of Dr. Mahdi Fawzi as Top R&D Executive
7. Jazz Pharmaceuticals plc Announces New Executive Appointments
8. BD Announces Webcast of Annual Meeting of Shareholders
9. Codexis Announces CFO Departure
10. Elanco Animal Health Announces Lillys Agreement to Acquire ChemGen Corp.
11. Span-America Announces First Quarter Conference Call on the Internet
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2017)... ORLANDO, Fla. , Oct. 2, 2017  AllianceRx ... services company formed by Walgreens and pharmacy benefit manager ... of its new brand, which included the unveiling of ... Fla. , as well as at a few ... introduces the new brand to patients, some of whom ...
(Date:10/2/2017)... The Rebound mobile app is poised to become ... tide of prescription drug addiction. The app empowers users to ... stepping down their dosage in a safe, controlled manner while ... the first 100,000 people to sign up will enjoy 3 ... ...
(Date:9/28/2017)... Cohen Veterans Bioscience and Early Signal Foundation ... and home sensors for real-time monitoring of patients with ... nonprofit organization focused on disruptive health solutions for rare ... system to record and integrate behavioral, cognitive, physiological and ... ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... 13, 2017 , ... While it’s often important to take certain medications during ... Austin, Texas, has identified a solution. , She developed a prototype for MOTION LIGHT-UP ... such, it eliminates the need to turn on a light when taking medication during ...
(Date:10/13/2017)... ... October 13, 2017 , ... Lori R. Somekh, founder ... of ElderCounsel, a national organization of elder law and special needs planning attorneys. “Membership ... rules. It also provides a forum to network with elder law attorneys nationwide,” said ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Global Healthcare ... scenic Alexandria Park in Milford, NJ. This free event, sponsored by Global Healthcare ... activity. The fun run is geared towards children of all ages; it is ...
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the ... “America On The Brink” is the creation of published author, William Nowers. Captain ... As a WWII veteran, he spent thirty years in the Navy. Following his ...
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ... the introduction of an innovative new design of the shoulder pad. The shoulder ... maximum comfort while controlling your pain while using cold therapy. By utilizing ice and ...
Breaking Medicine News(10 mins):